How ICON Public Limited Company stacks up

ICLR · against 454 other Healthcare companies listed in US-listed

Growth

17/ 100

Near the bottom of its peers.

Ranked #393 of 455 · scores higher than 13% of peers

Bars: peers in each 10-point band of the growth score

26 peers with a growth score of 10–19, including ICLR · Click a bar to see the companies

Why growth scores 17?

Weighted metrics compared with all Healthcare companies.

Mainly because of its earnings per share growth, 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.

slower growth in earnings per share: weaker than 99% of peers. Earnings per share growth: -95.1% vs peer median 9.8%
slower revenue growth over three years: weaker than 66% of peers. 3-year revenue growth: 1.7% vs peer median 5.8%
slower revenue growth over the last year: weaker than 65% of peers. Revenue growth: 1.7% vs peer median 6.1%

Metric by metric

Position: dot = ICLR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	ICLR	Peer median	Better than	Weight
Revenue growthHigher is better · 475 reported	1.7%	11.0%	26%	33%
Earnings per share growthHigher is better · 171 reported	-95.1%	21.2%	0%	33%
3-year revenue growthHigher is better · 433 reported	1.7%	11.0%	24%	33%

Ranking by growth score

Top 5 and the companies ranked around ICLR

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
388	MiMedx Group, Inc.MDXG · US-listed	474M USD	18	46
388	Ocular Therapeutix, Inc.OCUL · US-listed	1.5B USD	18	30
388	Puma Biotechnology, Inc.PBYI · US-listed	528M USD	18	58
393	ADC Therapeutics SAADCT · US-listed	198M USD	17	10
393	ICON Public Limited CompanyICLR · US-listed	15.7B USD	17	33
393	Recursion Pharmaceuticals, Inc.RXRX · US-listed	2.0B USD	17	24
396	Anteris Technologies Global Corp.AVR · US-listed	546M USD	16	31
396	Standard BioTools Inc.LAB · US-listed	239M USD	16	38
398	NRC HealthNRC · US-listed	532M USD	15	34

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…